Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2018 When Should Iatrogenic Polypharmacy Be Considered a Disease? Christine Wieseler, PhD When symptoms of polypharmacy are consistent with those of difficult-to-diagnose disorders, reliable determinations about which drugs are necessary is critical. AMA J Ethics. 2018;20(12):E1133-1138. doi: 10.1001/amajethics.2018.1133. Podcast Sep 2022 Author Interview: “Why Improving Low-Wage Health Care Jobs Is Critical for Health Equity” Dr Mignon Duffy joins Ethics Talk to discuss her article: “Why Improving Low-Wage Health Care Jobs Is Critical for Health Equity.” Policy Forum Sep 2022 Why Improving Low-Wage Health Care Jobs Is Critical for Health Equity Mignon Duffy, PhD Commitment to health equity demands higher pay, improved benefits, and more workplace protections for all health workers. AMA J Ethics. 2022;24(9):E871-875. doi: 10.1001/amajethics.2022.871.
Case and Commentary Dec 2018 When Should Iatrogenic Polypharmacy Be Considered a Disease? Christine Wieseler, PhD When symptoms of polypharmacy are consistent with those of difficult-to-diagnose disorders, reliable determinations about which drugs are necessary is critical. AMA J Ethics. 2018;20(12):E1133-1138. doi: 10.1001/amajethics.2018.1133.
Podcast Sep 2022 Author Interview: “Why Improving Low-Wage Health Care Jobs Is Critical for Health Equity” Dr Mignon Duffy joins Ethics Talk to discuss her article: “Why Improving Low-Wage Health Care Jobs Is Critical for Health Equity.”
Policy Forum Sep 2022 Why Improving Low-Wage Health Care Jobs Is Critical for Health Equity Mignon Duffy, PhD Commitment to health equity demands higher pay, improved benefits, and more workplace protections for all health workers. AMA J Ethics. 2022;24(9):E871-875. doi: 10.1001/amajethics.2022.871.